Netherlands - Global health

Download
Download

The Netherlands’ total official development assistance (ODA) to health in 2019 was US$540 million, making it the seventh-largest Organisation for Economic Cooperation and Development (OECD) Development Assistance Committee (DAC) donor to health. Health ODA made up 10% of total Dutch ODA in 2019, putting the Netherlands slightly above the DAC average of 8% and making it the eighth-largest donor in relative terms. Of the US$540 million in ODA to health in 2019, 45% was made up of core contributions to multilaterals, 19% was earmarked funding to multilaterals (reported as bilateral funding), and the remainder (37%) was provided bilaterally.  

Bilateral health ODA fell by 17%, from US$239 million in 2018 to US$199 in 2019. The decrease was primarily driven by cuts in funding to the subsectors of basic nutrition, sexually transmitted disease (STD) control (including HIV/AIDS), and health policy and administrative management. Although the SRHR sectors took some cuts in 2019, bilateral health funding strongly focused on sexual and reproductive health and rights (SRHR), in line with the Netherlands’ policy priorities.  In 2019, over half of all bilateral health funding went to reproductive health care (58%). This was followed by population policy and administrative management (11%), and basic nutrition (10%).

The Dutch government is a global leader on SRHR and it strongly prioritizes this issue in its health-related assistance. The Netherlands supports civil society organizations (CSOs) and multilaterals active in the field of SRHR; funding for SRHR CSOs in 2021-2025 will be channeled through the ‘SRHR Partnership Fund’ (€315 million, or US$353 million; a total of €63 million, or US$71 million annually; see Sector: ‘Gender equality’). The Netherlands also plans to contribute US$68 million between 2018 and 2023 to the Global Financing Facility in support of Every Woman Every Child (GFF; a financing mechanism that acts as a catalyst to mobilize financing for government plans to invest in health care for women, children, and adolescents), topped up by an additional €10 million (US$11 million) in May of 2021 to be spent on Family Planning, with UNFPA and GFF listed as the implementers.

In response to fears that spending on COVID-19 could compromise the Netherlands’ traditional SRHR focus, the former Dutch Minister of Foreign Trade and Development Cooperation, Sigrid Kaag, recently reiterated her support commitment to funding HIV/AIDS programs through multilateral partners, including UNAIDS, Aidsfonds, Frontline AIDS, Robert Carr Fund, the Love Alliance, and the Global Fund, and confirmed the distribution of €70 million (US$78 million) for HIV/AIDS within the SRHR 2021 budget.  

The Netherlands has not released a written policy on its global response to the COVID-19 pandemic, instead making ad hoc pledges to multilateral organizations. In October of 2021, the Netherlands pledged an additional €15million (US$17 million) to ACT-A, bringing its total contributions up to €225 (US$252 million).

In December of 2021, after nine months of coalition talks, the Dutch formation parties finalized their coalition agreement, which included a) a structural increase of ODA of an average of €388 million (US$445 million) per year (however, the actual amount increases over the years, starting at €318 million (US$364) and reaching €556 million (US$638 million) in 2025); b) funding increases to major multilaterals including COVAX; and c) a recommitment to the ongoing development of the Dutch global health strategy, with the goal of eliminating tuberculosis and HIV by 2030.